Back
Aardvark Therapeutics Stock Price Chart

Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
AARD
Aardvark Therapeutics
Last Price:
$7.06
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7

[Urgent Alert] This unique trade could land you 100% gains in 10 days
Discover how much you can make with this "Friday Phenomenon."-
The current trend is relatively stagnant and AARD is experiencing slight selling pressure.
Aardvark Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.9 | Sell |
20-day SMA: | 8.54 | Sell |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 7.69 | Sell |
20-day EMA: | 8.31 | Sell |
50-day EMA: | 7.36 | Sell |
200-day EMA: | 3.19 | Buy |
Aardvark Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.34 | Sell |
Relative Strength Index (14 RSI): | 36.37 | Sell |
Chaikin Money Flow: | -4923 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.82 - 9.9) | Sell |
Bollinger Bands (100): | ( - ) | Buy |
Aardvark Therapeutics Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aardvark Therapeutics Stock
Is Aardvark Therapeutics Stock a Buy?
-
Aardvark Therapeutics share price is 7.14 while AARD 8-day simple moving average is 7.90, which is a Sell signal.
-
The stock price of AARD is 7.14 while Aardvark Therapeutics 20-day SMA is 8.54, which makes it a Sell.
-
Aardvark Therapeutics 50-day simple moving average is 0.00 while AARD share price is 7.14, making it a Buy technically.
-
AARD stock price is 7.14 and Aardvark Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.
AARD Technical Analysis vs Fundamental Analysis
Sell
25
Aardvark Therapeutics (AARD)
is a Sell
Is Aardvark Therapeutics a Buy or a Sell?
-
Aardvark Therapeutics stock is rated a SellThe current Aardvark Therapeutics [AARD] share price is $7.14. The Score for AARD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Aardvark Therapeutics Stock Info
Market Cap:
154.9M
Price in USD:
7.14
Share Volume:
30.4K
Aardvark Therapeutics 52-Week Range
52-Week High:
19.58
52-Week Low:
4.88
Sell
25
Aardvark Therapeutics (AARD)
is a Sell
Aardvark Therapeutics Share Price Forecast
-
What is the Aardvark Therapeutics stock price today?The Aardvark Therapeutics stock price is 7.14 USD today.
-
Will AARD stock go up or go down?Aardvark Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aardvark Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aardvark Therapeutics is overvalued.
Is Aardvark Therapeutics Stock a Buy?
-
Aardvark Therapeutics share price is 7.14 while AARD 8-day exponential moving average is 7.69, which is a Sell signal.
-
The stock price of AARD is 7.14 while Aardvark Therapeutics 20-day EMA is 8.31, which makes it a Sell.
-
Aardvark Therapeutics 50-day exponential moving average is 7.36 while AARD share price is 7.14, making it a Sell technically.
-
AARD stock price is 7.14 and Aardvark Therapeutics 200-day simple moving average is 3.19, creating a Buy signal.
Fundamental Analysis of Aardvark Therapeutics
Is Aardvark Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.96 per share, and an increase next year of $0.13 per share.
Technical Analysis of Aardvark Therapeutics
Should I short Aardvark Therapeutics stock?
-
AARD Moving Average Covergence Divergence (MACD) indicator is -0.34, suggesting Aardvark Therapeutics is a Sell
-
Aardvark Therapeutics Relative Strength Index (RSI) is 36.37, which suggest Aardvark Therapeutics is oversold
-
The Bollinger Bands (25) for Aardvark Therapeutics is (7.82 - 9.9), which suggest Aardvark Therapeutics is a Buy
-
The Bollinger Bands (100) for Aardvark Therapeutics is ( - ), which suggest Aardvark Therapeutics is a Buy
* Aardvark Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.